
1. Cancer Cell. 2021 Nov 8;39(11):1445-1447. doi: 10.1016/j.ccell.2021.10.003. Epub 
2021 Oct 12.

Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA 
vaccination in patients with cancer.

McKenzie DR(1), Mu√±oz-Ruiz M(1), Monin L(1), Alaguthurai T(2), Lechmere T(3),
Abdul-Jawad S(4), Graham C(3), Pollock E(5), Graham R(4), Sychowska K(5), Seow
J(3), Tremain C(6), Gousis C(6), Domingo-Vila C(5), Cooper J(6), Vidler J(7),
Owczarczyk K(6), Swampillai A(8), Kristeleit H(6), Malim MH(3), Fields P(9),
Patten PEM(10), Papa S(9), North BV(11), Tree T(5), Doores KJ(3), Hayday AC(12), 
Irshad S(13).

Author information: 
(1)The Francis Crick Institute, London, UK.
(2)Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences,
King's College London, UK; Breast Cancer Now Research Unit, King's College
London, London, UK.
(3)Department of Infectious Diseases, School of Immunology and Microbial
Sciences, King's College London, UK.
(4)Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences,
King's College London, UK.
(5)Peter Gorer Department of Immunobiology, School of Immunology and Microbial
Sciences, King's College London, UK.
(6)Guy's and St. Thomas' NHS Foundation Trust, London, UK.
(7)Department of Haematological Medicine, King's College Hospital, London, UK.
(8)Breast Cancer Now Research Unit, King's College London, London, UK; Guy's and 
St. Thomas' NHS Foundation Trust, London, UK.
(9)Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences,
King's College London, UK; Guy's and St. Thomas' NHS Foundation Trust, London,
UK.
(10)Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences,
King's College London, UK; Department of Haematological Medicine, King's College 
Hospital, London, UK.
(11)Clinical Trials Unit, King's College London, UK.
(12)The Francis Crick Institute, London, UK; Peter Gorer Department of
Immunobiology, School of Immunology and Microbial Sciences, King's College
London, UK.
(13)Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences,
King's College London, UK; Breast Cancer Now Research Unit, King's College
London, London, UK; Guy's and St. Thomas' NHS Foundation Trust, London, UK;
Cancer Research UK (CRUK) Clinician Scientist, London, UK. Electronic address:
sheeba.irshad@kcl.ac.uk.

DOI: 10.1016/j.ccell.2021.10.003 
PMCID: PMC8506107
PMID: 34678151  [Indexed for MEDLINE]

Conflict of interest statement: Declaration of interests The authors declare no
competing interests.

